USP15 stabilizes TGF-β receptor I and promotes oncogenesis through the activation of TGF-β signaling in glioblastoma (original) (raw)

• Furnari, F.B. et al. Malignant astrocytic glioma: genetics, biology, and paths to treatment. Genes Dev. 21, 2683–2710 (2007).
  Article CAS Google Scholar
• Holland, E.C. Gliomagenesis: genetic alterations and mouse models. Nat. Rev. Genet. 2, 120–129 (2001).
  Article CAS Google Scholar
• Maher, E.A. et al. Malignant glioma: genetics and biology of a grave matter. Genes Dev. 15, 1311–1333 (2001).
  Article CAS Google Scholar
• Zhu, Y. & Parada, L.F. The molecular and genetic basis of neurological tumours. Nat. Rev. Cancer 2, 616–626 (2002).
  Article CAS Google Scholar
• Rich, J.N. The role of transforming growth factor-β in primary brain tumors. Front. Biosci. 8, e245–e260 (2003).
  Article CAS Google Scholar
• Bruna, A. et al. High TGFβ-Smad activity confers poor prognosis in glioma patients and promotes cell proliferation depending on the methylation of the PDGF-B gene. Cancer Cell 11, 147–160 (2007).
  Article CAS Google Scholar
• Peñuelas, S. et al. TGF-β increases glioma-initiating cell self-renewal through the induction of LIF in human glioblastoma. Cancer Cell 15, 315–327 (2009).
  Article Google Scholar
• Anido, J. et al. TGF-β receptor inhibitors target the CD44(high)/Id1(high) glioma-initiating cell population in human glioblastoma. Cancer Cell 18, 655–668 (2010).
  Article CAS Google Scholar
• Ikushima, H. et al. Autocrine TGF-β signaling maintains tumorigenicity of glioma-initiating cells through Sry-related HMG-box factors. Cell Stem Cell 5, 504–514 (2009).
  Article CAS Google Scholar
• Massagué, J., Seoane, J. & Wotton, D. Smad transcription factors. Genes Dev. 19, 2783–2810 (2005).
  Article Google Scholar
• Itoh, S. & ten Dijke, P. Negative regulation of TGF-β receptor/Smad signal transduction. Curr. Opin. Cell Biol. 19, 176–184 (2007).
  Article CAS Google Scholar
• Wicks, S.J. et al. Reversible ubiquitination regulates the Smad/TGF-β signalling pathway. Biochem. Soc. Trans. 34, 761–763 (2006).
  Article CAS Google Scholar
• Kavsak, P. et al. Smad7 binds to Smurf2 to form an E3 ubiquitin ligase that targets the TGF β receptor for degradation. Mol. Cell 6, 1365–1375 (2000).
  Article CAS Google Scholar
• Ogunjimi, A.A. et al. Regulation of Smurf2 ubiquitin ligase activity by anchoring the E2 to the HECT domain. Mol. Cell 19, 297–308 (2005).
  Article CAS Google Scholar
• Lee, B.H. et al. Enhancement of proteasome activity by a small-molecule inhibitor of USP14. Nature 467, 179–184 (2010).
  Article CAS Google Scholar
• Schweitzer, K., Bozko, P.M., Dubiel, W. & Naumann, M. CSN controls NF-κB by deubiquitinylation of IκBα. EMBO J. 26, 1532–1541 (2007).
  Article CAS Google Scholar
• Xu, M. et al. USP15 plays an essential role for caspase-3 activation during Paclitaxel-induced apoptosis. Biochem. Biophys. Res. Commun. 388, 366–371 (2009).
  Article CAS Google Scholar
• Huang, X., Langelotz, C., Hetfeld-Pechoc, B.K., Schwenk, W. & Dubiel, W. The COP9 signalosome mediates β-catenin degradation by deneddylation and blocks adenomatous polyposis coli destruction via USP15. J. Mol. Biol. 391, 691–702 (2009).
  Article CAS Google Scholar
• Inui, M. et al. USP15 is a deubiquitylating enzyme for receptor-activated SMADs. Nat. Cell Biol. 13, 1368–1375 (2011).
  Article CAS Google Scholar
• Brummelkamp, T.R., Bernards, R. & Agami, R. A system for stable expression of short interfering RNAs in mammalian cells. Science 296, 550–553 (2002).
  Article CAS Google Scholar
• Nijman, S.M. et al. A genomic and functional inventory of deubiquitinating enzymes. Cell 123, 773–786 (2005).
  Article CAS Google Scholar
• Moretti, J. et al. The translation initiation factor 3f (eIF3f) exhibits a deubiquitinase activity regulating Notch activation. PLoS Biol. 8, e1000545 (2010).
  Article Google Scholar
• Nakao, A. et al. Identification of Smad7, a TGFβ-inducible antagonist of TGF-β signalling. Nature 389, 631–635 (1997).
  Article CAS Google Scholar
• Papa, F.R. & Hochstrasser, M. The yeast DOA4 gene encodes a deubiquitinating enzyme related to a product of the human Tre-2 oncogene. Nature 366, 313–319 (1993).
  Article CAS Google Scholar
• Ebisawa, T. et al. Smurf1 interacts with transforming growth factor-β type I receptor through Smad7 and induces receptor degradation. J. Biol. Chem. 276, 12477–12480 (2001).
  Article CAS Google Scholar
• Wiesner, S. et al. Autoinhibition of the HECT-type ubiquitin ligase Smurf2 through its C2 domain. Cell 130, 651–662 (2007).
  Article CAS Google Scholar
• Cancer Genome Atlas Research Network. Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature 455, 1061–1068 (2008).
• Cancer Genome Atlas Research Network. Integrated genomic analyses of ovarian carcinoma. Nature 474, 609–615 (2011).
• Seoane, J. The TGFβ pathway as a therapeutic target in cancer. Clin. Transl. Oncol. 10, 14–19 (2008).
  Article CAS Google Scholar
• Rodon et al. First human dose (FHD) study of the oral transforming growth factor-β (TGFβ) receptor I kinase inhibitor LY2157299 in patients with treatment-refractory malignant glioma. J. Clin. Oncol. 29 (suppl.) abstr. 3011 (2011).
• Oettle et al. Phase I/II study with trabedersen (AP 1009) monotherapy for the treatment of patients with advanced pancreatic cancer, malignant melanoma, and colorectal carcinoma. Am. Soc. Clin. Oncology (2011).
• Zhu, H., Kavsak, P., Abdollah, S., Wrana, J.L. & Thomsen, G.H.A. SMAD ubiquitin ligase targets the BMP pathway and affects embryonic pattern formation. Nature 400, 687–693 (1999).
  Article CAS Google Scholar
• Zhang, Y., Chang, C., Gehling, D.J., Hemmati-Brivanlou, A. & Derynck, R. Regulation of Smad degradation and activity by Smurf2, an E3 ubiquitin ligase. Proc. Natl. Acad. Sci. USA 98, 974–979 (2001).
  Article CAS Google Scholar
• Hata, A., Lagna, G., Massagué, J. & Hemmati-Brivanlou, A. Smad6 inhibits BMP/Smad1 signaling by specifically competing with the Smad4 tumor suppressor. Genes Dev. 12, 186–197 (1998).
  Article CAS Google Scholar
• Kamitani, T., Kito, K., Nguyen, H.P. & Yeh, E.T. Characterization of NEDD8, a developmentally down-regulated ubiquitin-like protein. J. Biol. Chem. 272, 28557–28562 (1997).
  Article CAS Google Scholar
• Günther, H.S. et al. Glioblastoma-derived stem cell–enriched cultures form distinct subgroups according to molecular and phenotypic criteria. Oncogene 27, 2897–2909 (2008).
  Article Google Scholar
• van der Eb, A.J. & Graham, F.L. Assay of transforming activity of tumor virus DNA. Methods Enzymol. 65, 826–839 (1980).
  Article CAS Google Scholar